Expertise in
7
conditions

Haitao X. Zhao

No. 100 Kexue Avenue, 
Zhengzhou, CN 
Expertise in
7
conditions
No. 100 Kexue Avenue, 
Zhengzhou, CN 

Overview

Haitao Zhao practices practicing medicine in Zhengzhou, China.

Zhao is highly rated in 7 conditions, according to our data. Their clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Gallbladder Cancer, Hepatectomy, and Hepato-Pancreato-Biliary Surgery.

They are actively involved in clinical research, co-authoring 350 peer reviewed articles and participating in 2 clinical trials.

Locations

No. 100 Kexue Avenue, Zhengzhou, 450001, China
Other Locations
Peking Union Medical College Hospital, Peking Union Medical College, Beijing, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2b, Open-label, Single-arm Study of ZW25 Monotherapy in Subjects With Advanced or Metastatic HER2-amplified Biliary Tract Cancers
A Phase 2b, Open-label, Single-arm Study of ZW25 Monotherapy in Subjects With Advanced or Metastatic HER2-amplified Biliary Tract Cancers
Enrollment Status: Completed
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drug: ZW25 (Zanidatamab)
Study Phase: Phase 2
A Randomized, Controlled, Open-label, Multicenter Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
A Randomized, Controlled, Open-label, Multicenter Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
Enrollment Status: Active_not_recruiting
Publish Date: February 20, 2025
Intervention Type: Drug
Study Drugs: AK105 Injection, Anlotinib Hydrochloride Capsules, Sorafenib Tosylate Tablets
Study Phase: Phase 3
View 1 Less Clinical Trial

350 Total Publications

mRNA cancer vaccines: delivery strategies, immune modulation, and clinical translation.
mRNA cancer vaccines: delivery strategies, immune modulation, and clinical translation.
Journal: Frontiers in pharmacology
Published: April 10, 2026

Frequently Asked Questions about Haitao X. Zhao

Is Haitao X. Zhao a top-rated expert for Cholangiocarcinoma (Bile Duct Cancer)?

MediFind is an objective health platform that identifies experts based on real-world data. Haitao X. Zhao is classified as an Distinguished expert for Cholangiocarcinoma (Bile Duct Cancer), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Haitao X. Zhao participate in research or clinical trials?

Yes. Haitao X. Zhao has published 350 articles and abstracts on conditions like Cholangiocarcinoma (Bile Duct Cancer). You can view a list of Haitao X. Zhao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhao's expertise for a condition
ConditionClose
    View All 34 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile